Cargando…

Prognostic value of microvessel density in stage II and III colon cancer patients: a retrospective cohort study

BACKGROUND: Microvessel density (MVD), as a derived marker for angiogenesis, has been associated with poor outcome in several types of cancer. This study aimed to evaluate the prognostic value of MVD in stage II and III colon cancer and its relation to tumour-stroma-percentage (TSP) and expression o...

Descripción completa

Detalles Bibliográficos
Autores principales:	den Uil, Sjoerd H., van den Broek, Evert, Coupé, Veerle M. H., Vellinga, Thomas T., Delis-van Diemen, Pien M., Bril, Herman, Belt, Eric J. Th., Kranenburg, Onno, Stockmann, Hein B. A. C., Belien, Jeroen A. M., Meijer, Gerrit A., Fijneman, Remond J. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6698008/ https://www.ncbi.nlm.nih.gov/pubmed/31420015 http://dx.doi.org/10.1186/s12876-019-1063-4

Ejemplares similares

MACROD2 expression predicts response to 5-FU-based chemotherapy in stage III colon cancer
por: van den Broek, Evert, et al.
Publicado: (2018)

Lumican and Versican Are Associated with Good Outcome in Stage II and III Colon Cancer
por: de Wit, Meike, et al.
Publicado: (2012)

Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence
por: den Uil, Sjoerd H, et al.
Publicado: (2016)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients
por: Lenos, Kristiaan, et al.
Publicado: (2015)

Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression
por: de Wit, Meike, et al.
Publicado: (2017)

High expression of secretory leukocyte protease inhibitor (SLPI) in stage III micro-satellite stable colorectal cancer is associated with reduced disease recurrence
por: Nugteren, Sandrine, et al.
Publicado: (2022)

A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9
por: Goos, Jeroen A.C.M., et al.
Publicado: (2015)

Postoperative circulating tumour DNA is associated with pathologic response and recurrence-free survival after resection of colorectal cancer liver metastases
por: Bolhuis, Karen, et al.
Publicado: (2021)

Presence of HIF-1 and related genes in normal mucosa, adenomas and carcinomas of the colorectum
por: Greijer, Astrid E., et al.
Publicado: (2008)

CD31-positive microvessel density within adenomas of Lynch Syndrome patients is similar compared to adenomas of non-Lynch patients
por: Vleugels, Jasper L.A., et al.
Publicado: (2019)

The Melanoma MAICare Framework: A Microsimulation Model for the Assessment of Individualized Cancer Care
por: van der Meijde, Elisabeth, et al.
Publicado: (2016)

Identification of key genes for carcinogenic pathways associated with colorectal adenoma-to-carcinoma progression
por: Sillars-Hardebol, Anke H., et al.
Publicado: (2010)

Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis
por: Goos, J A C M, et al.
Publicado: (2013)

Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control Study
por: Jodal, Henriette C., et al.
Publicado: (2023)

Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis
por: Nugteren, Sandrine, et al.
Publicado: (2020)

GeneBreak: detection of recurrent DNA copy number aberration-associated chromosomal breakpoints within genes
por: van den Broek, Evert, et al.
Publicado: (2017)

Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases
por: Goos, J A C M, et al.
Publicado: (2014)

Consensus molecular subtype classification of colorectal adenomas
por: Komor, Malgorzata A, et al.
Publicado: (2018)

Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression
por: Komor, Malgorzata A., et al.
Publicado: (2019)

Lymph Node Negative Colorectal Cancers with Isolated Tumor Deposits Should Be Classified and Treated As Stage III
por: Belt, E. J. Th., et al.
Publicado: (2010)

Paving the Road Towards Non-Invasive Molecular Imaging
por: Fijneman, Remond J.A.
Publicado: (2006)

Genetic Predisposition to Sporadic Cancer: How to Handle Major Effects of Minor Genes?
por: Fijneman, Remond J. A.
Publicado: (2005)

tranSMART
por: Bierkens, Mariska, et al.
Publicado: (2015)

Extent and location of tumor infiltrating lymphocytes in microsatellite stable colon cancer predict outcome to adjuvant active specific immunotherapy
por: Turksma, Annelies, et al.
Publicado: (2015)

Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
por: Sluiter, N. R., et al.
Publicado: (2016)

Predicting early extrahepatic recurrence after local treatment of colorectal liver metastases
por: Wensink, G E, et al.
Publicado: (2023)

Paired image- and FACS-based toxicity assays for high content screening of spheroid-type tumor cell cultures
por: Trumpi, Kari, et al.
Publicado: (2015)

Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer
por: Snoeren, N, et al.
Publicado: (2013)

Detection of tumor‐derived cell‐free DNA from colorectal cancer peritoneal metastases in plasma and peritoneal fluid
por: van't Erve, Iris, et al.
Publicado: (2021)

High Prevalence and Clinical Relevance of Genes Affected by Chromosomal Breaks in Colorectal Cancer
por: van den Broek, Evert, et al.
Publicado: (2015)

Angiogenesis-Related Markers and Prognosis After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer
por: de Cuba, E. M. V., et al.
Publicado: (2016)

Performance of four platforms for KRAS mutation detection in plasma cell-free DNA: ddPCR, Idylla, COBAS z480 and BEAMing
por: Vessies, D. C. L., et al.
Publicado: (2020)

Cystathionine γ-lyase is expressed in human atherosclerotic plaque microvessels and is involved in micro-angiogenesis
por: van den Born, J. C., et al.
Publicado: (2016)

High Lymph Node Yield is Related to Microsatellite Instability in Colon Cancer
por: Belt, E. J. Th., et al.
Publicado: (2011)

Oxidative Stress and Microvessel Barrier Dysfunction
por: He, Pingnian, et al.
Publicado: (2020)

External Validation of Two Established Clinical Risk Scores Predicting Outcome after Local Treatment of Colorectal Liver Metastases in a Nationwide Cohort
por: Bolhuis, Karen, et al.
Publicado: (2022)

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study.
por: Vermeulen, P. B., et al.
Publicado: (1995)

Modeling Personalized Adjuvant TreaTment in EaRly stage coloN cancer (PATTERN)
por: Jongeneel, Gabrielle, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_kcl9i4b14asdnqltu3idccfi5r